Elissa Driggin

TL;DR: The current understanding of the pathogenesis, epidemiology, management and outcomes of patients with COVID-19 who develop venous or arterial thrombosis, and of those with preexistingThrombotic disease who develop CO VID-19 are reviewed.

TL;DR: The peer-reviewed and preprint literature pertaining to cardiovascular considerations related to COVID-19 are reviewed to highlight gaps in knowledge that require further study pertinent to patients, health care workers, and health systems.

TL;DR: Novel dosing approaches are described for commonly used antithrombotic agents (especially heparin-based regimens) and the potential use of less widely used antithsombotic drugs in the absence of confirmed thrombosis.

TL;DR: In this paper, the authors present the overall considerations of both exposure and clinical risk needed for vaccine allocation efforts; present the specific evidence and risk considerations related to CVD and COVID-19; and propose a schema of CV risk to incorporate into vaccine allocation decisions.

TL;DR: A review of available nutritional status assessment tools for patients with heart failure can be found in this paper , where the feasibility and challenges associated with multimodal nutrition interventions and delineate potential solutions to facilitate addressing nutrition in patients with HF.